Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

Research analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the stock.

Milestone Scientific Price Performance

Milestone Scientific stock opened at $0.65 on Thursday. The firm has a market capitalization of $49.79 million, a P/E ratio of -6.50 and a beta of 0.94. The stock has a fifty day moving average price of $0.65 and a two-hundred day moving average price of $0.69. Milestone Scientific has a 52-week low of $0.52 and a 52-week high of $1.35.

Milestone Scientific (NYSE:MLSS) last posted its earnings results on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%. The firm had revenue of $2.26 million during the quarter.

Institutional Investors Weigh In On Milestone Scientific

A hedge fund recently bought a new stake in Milestone Scientific stock. AE Wealth Management LLC acquired a new position in Milestone Scientific Inc. (NYSE:MLSS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 27,936 shares of the company’s stock, valued at approximately $26,000. 5.79% of the stock is owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.